Robocallers are auto-dialing hospitals, tying up lines that need to be free for patient emergencies.
Sara is a credited freelance writer, editor, contributor, and essayist, as well as a novelist and poet with over sixteen years of experience. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She has an MBA degree with a concentration in Marketing and is currently pursuing an MA in Clinical Mental Health Counseling, concentrating in Substance Abuse and Addictions. Sara is also certified in children's book writing, HTML coding and social media marketing. Her fourth book, Narcissistic Abuse: A Survival Guide was released in December 2017 and is now available on Amazon. For more information, please visit sarateller.com.
Kelsey Mulvey, 27, used her position as a nurse to steal opioids meant for cancer patients.
Lawmakers and consumer advocates try to ban rocking infant sleepers with inclinations of over ten degrees.
Judge Michael Stelzer has kept an injunction in place, allowing a Missouri clinic to continue operating until the state makes a final decision.
Jury convicts former dean of Michigan State University’s (MSU) College of Osteopathic Medicine, William Strampel, on charges of misconduct in office and two counts of willful neglect of duty.
Long-time University of California, Los Angeles gynecologist has been accused by give women of sexual assault.
National Nurses United has filed a complaint with the Illinois Department of Public Health and the federal Occupational Safety & Health Administration on behalf of University of Chicago Medical Center nurses who say they are working far too many hours.
Judge says Oklahoma needs to prove that settlement funds from opioid litigation comply with a new state law.
Police beat meth user into a coma and now Sacramento will pay $5.2 million.
Phoenix-based opioid manufacturer Insys Therapeutics has officially filed for Chapter 11 bankruptcy protection just five days after agreeing to pay $225 million to settle the litigation against it concerning the powerful fentanyl spray, Subsys. Insys asked the court to “allow it to sell its assets to pay more than $250 million in debts,” according to